A human normal counterpart of cd4+ cd56+ cutaneous neoplasm

Details A human normal counterpart of cd4+ cd56+ cutaneous neoplasm A human normal counterpart of cd4+ cd56+ cutaneous neoplasm

C - Chemistry, Metallurgy

12

N

C12N 5/06 (2006.01) A61K 38/17 (2006.01) A61K 39/00 (2006.01) A61K 39/395 (2006.01) A61K 47/48 (2006.01) A61P 35/00 (2006.01) C07K 16/28 (2006.01) C12N 5/08 (2006.01) C12Q 1/02 (2006.01)

Patent

CA 2392400

The invention is directed to purified and isolated novel CD56+ plasmacytoid monocytes, the healthy counterpart of CD4+ CD56+ cutaneous neoplasm, and uses thereof.

L'invention concerne de nouveaux monocytes plasmacytoïdes CD56?+¿ purifiés et isolés, l'homologue sain du néoplasme cutané CD4?+¿CD56?+¿ et leurs utilisations.

Affiliated with

Also associated with

Rating

A human normal counterpart of cd4+ cd56+ cutaneous neoplasm does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with A human normal counterpart of cd4+ cd56+ cutaneous neoplasm, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A human normal counterpart of cd4+ cd56+ cutaneous neoplasm will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1888114